Weiwei Lu

Weiwei Lu

Auto-generated profile, based on publicly available information

Weiwei Lu

Department of Blood Transfusion, The First Hospital of Jilin University, Changchun, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2021 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
YXYunhe Xu
Yunhe Xu
XWXiaoning Wang
Xiaoning Wang
WLWenshu Liu
Wenshu Liu
WLWeiwei Lu
Weiwei Lu
Background: Platelet-rich plasma (PRP) has the potential to be used for bone regeneration. However, its effect on osteogenic differentiation of human periodontal ligament stem cells (hPDLSCs) and its effect on cell autophagy of hPDLSCs remain unknown. In this study, we investigated the effects of PRP on cell viability and osteogenic differentiation of hPDLSCs and the underlying molecular mechanisms.Methods: hPDLSCs were isolated and identified by morphology and flow cytometry analysis. Next, thrombin-activated PRP was used to stimulate hPDLSCs. The MTT assay was used to analyze cell viability. Osteogenic differentiation was investigated using alkaline phosphatase (ALP) activity assay, alizarin red S (ARS) staining, and gene expression analysis of osteogenic markers. Expression of the autophagic proteins was determined using western blotting.Results: Thrombin-activated PRP significantly enhanced cell viability, ALP activity, osteogenic-related mRNA levels and alizarin red-mineralization activity in hPDLSCs in a dose-dependent manner. Furthermore, activated PRP dose-dependently increased LC3-II/I ratio and the expression of SIRT1 and Beclin-1. PRP treatment also enhanced the autophagic flux. It was also demonstrated that the inhibition of SIRT1 using sirtinol or suppression of autophagy by 3-methyladenine (3-MA) abrogated PRP-induced viability and osteogenic differentiation of hPDLSCs.Conclusion: Our study suggested that thrombin-activated PRP accelerated the viability and osteogenic differentiation of hPDLSCs via SIRT1-mediated autophagy induction.

1 September 2025 in International Journal of Women's Health
Verified
Journal Article
Open access
PDF file
PLPanbo Liu
Panbo Liu
XMXinyu Miao
Xinyu Miao
QXQiqi Xu
Qiqi Xu
ZLZhuoyao Li
Zhuoyao Li
WLWeiwei Lu
Weiwei Lu
JLjiajia LI
jiajia LI
Background: Cervical adenosquamous carcinoma (ASC) has a poor prognosis, and brain metastasis (BM) is extremely rare. Patients with BM have a poor prognosis. At present, there is no satisfactory treatment and no standard effective treatment. In recent years, immune checkpoint inhibitors (ICIs) and surgical treatment have emerged as a promising treatment for recurrent and metastatic cervical cancer (CC). Case: We report a 39-year-old CC patient whose cervical biopsy pathology showed adenocarcinoma with stage IIIC1r, and so underwent radical radiotherapy and chemotherapy 7 years ago. She was under a palliative enterostomy 4 years ago after intestinal perforation due to multiple recurrence of pelvic tumor. To our surprise, postoperative histopathology was squamous cell carcinoma and adenocarcinoma, ASC was confirmed. The postoperative efficacy of intravenous chemotherapy combined with immunotherapy was partial response (PR), and the efficacy of immunomaintenance therapy was progressive disease (PD). While she had gone through the recurrence of intestinal leakage 3 years ago, Pelvic exenteration (PE) was performed (postoperative histopathology squamous cell carcinoma), the postoperative effect was complete response (CR), and the patient selected regular reexamination. Isolated BM focus was developed in August 2024, and radiotherapy, chemotherapy and immunotherapy were refused after surgical treatment (postoperative histopathology adenocarcinoma). The progression-free survival (PFS) after BM is nearly one year. At present, the patient’s reexamination showed no obvious abnormality. Conclusion: We report a case of ASC, whose at the initial treatment, the cervical lesions were mainly adenocarcinoma. However, pelvic metastatic lesion was mainly squamous carcinoma and underwent chemotherapy combined with immunotherapy combined with PE. The histopathology form of BM is adenocarcinoma. The surgical treatment has achieved remarkable curative effect and survival benefit.The choice of treatment is often based on the number of metastases in the patient’s clinical state, tumor size, and metastases in other organs.

26 December 2025 in Medicine
Verified
Journal Article
Open access
WLWeiwei Lu
Weiwei Lu
CMChunping Mo
Chunping Mo
JZJing Zhong
Jing Zhong
YZYan Zhang
Yan Zhang
LLLingbo Li
Lingbo Li
Rationale: The ABO blood group system typically includes 4 phenotypes: type A, type B, type O, and type AB. ABO subtypes refer to further subdivisions within these 4 blood types. We report a case of subtype A, focusing on elucidating the molecular mechanisms of this rare genotype. Patient concerns: The patient is a 34-year-old pregnant woman at 39 weeks gestation presenting with preterm labor. She exhibits forward and reversed stereotypic incompatibility. Diagnoses: All exons of ABO were amplified by PCR and sequenced using Sanger sequencing. Furthermore, only the seventh exon was sequenced by TA cloning for haplotype analysis. Sequencing analysis revealed that the genotypes ABO*A1.02 and ABO*O.01.02 , and the mutation c.565A > G, which has never been reported for the A allele, occurred based on ABO*A1.02 . Interventions: In addition to serological test, the patient underwent further molecular biology test. Outcomes: It led to identify a novel allele with subtype A serological characteristics, caused by the c.565A > G variant, which leads to a weakened A antigen. Lessons: Given its rarity, it is advisable to employ dual serological and molecular biological testing mechanisms during complex ABO blood typing to prevent missed detection and misclassifications, thereby effectively promoting transfusion and compatibility safety.